Amgen to establish Science and Innovation Center in TelanganaIllustrative image – not actual.

Amgen plans to establish a new Science and Innovation Center at Genome Valley in Hyderabad, Telangana, expanding its global research and development network  in India.

The new facility is expected to become operational in 2027 and will bring together scientists and technologists specialising in drug metabolism and precision medicine. The center will work closely with Amgen’s research laboratories worldwide to accelerate the discovery and development of innovative medicines. The facility will combine advanced scientific capabilities with data and digital technologies, supporting faster, more precise and efficient drug development. Genome Valley’s established scientific ecosystem and infrastructure were key factors supporting the company’s expansion in Hyderabad.

The new centre will complement Amgen’s existing technology and innovation site in the city, enabling greater integration between laboratory-based research and technology-driven capabilities. The expansion further strengthens Hyderabad’s position as a major life sciences and biotechnology hub in India.

← All latest storiesBack to top →